Competitive Analysis in the Healthcare Industry

We assisted one of our clients in the pharmaceutical field in carrying out regular competitive intelligence on the biosimilars of one of its drugs.

Before launching our monitoring, our team carried out a scoping stage by interviewing the various stakeholders involved in this monitoring, internally at our client’s site, in order to precisely define the elements of value for each (new regulations, announcements from manufacturers in the market, new partnerships published, new clinical results, etc.).

For more than 3 years, Alcimed has been leading the community of internal contributors (Market Access, Pricing, Regulatory teams) to publish a regular monitoring bulletin, synthetic and original!

Alcimed helped a major pharma player to understand how their competitors in the space were able to accelerate their mRNA manufacturing process for phase 1 clinical trials.

To do so, our team mapped and evaluated the connected networks of CDMOs used to test and produce mRNA for preclinical testing transitioning into GMP samples needed for clinical trials. Then, we analyzed the development timelines and strategies used by competitors in order to conduct a gap analysis of our client’s current manufacturing process.

With these identified gaps, we built an action plan to increase mRNA manufacturing speed as well as provided recommendations to our client on key criteria for leapfrogging their competition.

Alcimed assisted a pharma company in better understanding its competitors’ external actions and partnerships made around the microbiome, in order to define their strengths, clarify the gaps and prepare the future.

Our team conducted extensive research to identify competitors and analyze their investments over the last 5 years, as well as investor relations, annual reports, press releases, co-patents, to map the ecosystem around the targeted players.

Through this investigation, we were able to provide our client with ID cards and key messages for each competitor, together with a key transversal analysis, including the identification of the main competitors, their most relevant partnerships in the 5 past years, and a clear vision of their investment history.

Alcimed supported a start-up in the launch of its innovative solution in Europe, helping it to better define the positioning of its product and a relevant marketing strategy. For this, two main steps were carried out during this project:

The identification and characterization of competing POCT solutions through an in-depth documentary analysis to map the competition and current practices, and through the conduct of interviews with influential people and experts in Europe (associations, specialized institutes)

The analysis of the main regulatory aspects in Europe and the questioning of our client’s market assumptions by analyzing the demand and the receptivity of its POCT solution via a literature review, the analysis of specialized databases, as well as through exchanges with around sixty people, potential clients and decision-makers.

Our project allowed our client to benefit from a complete analysis of the legislation, the receptivity of its product by its future users, obstacles and market levers and in practice, pricing, information on contracts and market sizing.

Our recommendations also enabled a prioritization of the markets according to their size and their receptivity, thus guiding the strategy for launching the solution.

In this project, our team conducted an in-depth exploration of the European osteoarthritis therapeutics market, to help a leading pharmaceutical company’s offer and positioning with their new regenerative medicine technique.

The investigation entailed the study of the competition, the available products and their prices, and the main treatments under development. Identification of direct and indirect competitors helped understand the opportunities and risks in the osteoarthritis therapeutics market, while being aware of key trends in the market.

Through the support of a tailored methodology, the project allowed to facilitate the product positioning within the market and the key market figures collected helped our client build a business plan and embark new investors in their project.

Our team worked with the CEO of a start-up to prepare for the launch of its automated ABO Point Of Care test device in Europe. Our client wanted to challenge and consolidate its assumptions about market supply and demand, in order to better define its marketing strategy and the positioning of its solution.

In 5 European countries, we began by analysing the competition and the reasons for the success/failure of other players, in order to validate the positioning of our client’s offering in its market environment. Our team then mapped and characterised the main blood transfusion segments, unmet needs, expectations and interest in the offering, and the positioning of our customer’s project from a demand perspective.

This investigative work enabled us to question and strengthen various market elements of our client’s business plan in order to validate the strategy for launching its offering in Europe.

Our team supported a medical device player in preparing the launch of one of its products on the Chinese market. In order to finalize its launch roadmap, and to validate its market positioning, our client called on our team to conduct a market study on competing offers in China.

To do so, our team conducted an in-depth bibliographic review, complemented by interviews with buyers and users of medical devices such as our client’s, in order to gather their knowledge of the current market offering and their expectations with regards to a new solution entering the market.

Our market study enabled our client to refine the positioning of its product and finalize its targeting plan and launch sequence.

Our team supported a client in the healthcare sector in the preparation and facilitation of a prospective exercise of competitive evolution by teams around the world. Our client was in a particularly competitive market environment and wished to project with its teams the evolution of its competitors in order to work now on action plans of differentiation and gain or maintain market share.

To do so, our team first analyzed the portfolios of the major competitors and their dynamics, then analyzed the other players in the ecosystem, who could either develop specific solutions or technological bricks, or hold strong positions on a niche sub-segment of the market. We then analyzed potential new entrants, based on market trends.

Based on all this, our team co-defined prospective scenarios with our client, in preparation for the facilitation of a global workshop in a “win-game” format, enabling the teams to be involved in identifying the strongest threats and defining actions to be implemented now to prepare for them proactively.